Magdalena Filip

Magdalena Filip

Auto-generated profile, based on publicly available information

Magdalena Filip

Instytut Rehabilitacji Klinicznej, Akademia Kultury Fizycznej im. Bronisława Czecha w Krakowie, Kraków, Polska

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
EMElżbieta Mirek
Elżbieta Mirek
MFMagdalena Filip
Magdalena Filip
KBKrzysztof Banaszkiewicz
Krzysztof Banaszkiewicz
MRMonika Rudzińska-Bar
Monika Rudzińska-Bar
JSJadwiga Szymura
Jadwiga Szymura
ASAndrzej Szczudlik
Andrzej Szczudlik
Huntington's disease (HD) is a neurodegenerative, progressive disorder of the central nervous system which causes significant gait and balance disturbances. This is a pilot study which aims to determine the effects of a physiotherapy programme with use of Proprioceptive Neuromuscular Facilitation (PNF) on gait and balance in HD patients. 30 HD patients aged 21–60 with genetically confirmed diagnosis participated in the study. Participants followed a 3-week-long PNF-based physiotherapy programme. Gait and balance were evaluated twice in each participant: first at baseline and then after the course of physiotherapy. The following methods were used for gait disturbances: Tinetti Gait Assessment Tool, Up and Go Test, Timed Walking Tests for 10 m and 20 m (TWT10m, TWT20m). Balance was assessed with use of Berg Balance Scale, Pastor Test and Functional Reach Test. There was a significant improvement in all measures of balance and gait. PNF-based physiotherapy is effective and safe in HD patients.

12 October 2017 in Frontiers in Neuroscience
Verified
Journal Article
Open access
EMElżbieta Mirek
Elżbieta Mirek
MFMagdalena Filip
Magdalena Filip
WCWiesław Chwała
Wiesław Chwała
KBKrzysztof Banaszkiewicz
Krzysztof Banaszkiewicz
MRMonika Rudzinska-Bar
Monika Rudzinska-Bar
ASAndrzej Szczudlik
Andrzej Szczudlik
Objective: A number of studies on gait disturbances have been conducted, however, no clear pattern of gait disorders was described The aim of the study was to characterize the gait pattern in HD patients by conducting analysis of mean angular movement changes the lower limb joints and trunk (kinematics parameters). Methods: The study group consisted of 30 patients with HD (17 women and 13 men). The reference data include the results of 30 healthy subjects (17 women and 13 men). Registration of gait with the Vicon 250 system was performed using passive markers attached to specific anthropometric points directly on the skin, based on the Golem biomechanical model (Oxford Metrics Ltd.). The research group and the control group were tested once. Results:Statistically significant (p<0.05) angular changes in gait cycle for HD patients were observed in: insufficient plantar flexion during Loading Response and Pre-swing phases; insufficient flexion of the knee joint during Initial Swing and Mid Swing phases; excessive flexion of the hip in Terminal Stance and Pre-Swing phases and over-normative forward inclination of the trunk in all gait phases. It should be noted that the group of patients with HD obtained, for all the mean angular movement changes higher standard deviation. Conclusion: A characteristic gait disorder common to all patients with HD occurring throughout the whole duration of the gait cycle is a pathological anterior tilt of the trunk. The results will significantly contribute to programming physiotherapy for people with HD, aimed at stabilizing the trunk in a position of extension during gait.

1 September 2018 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
EMElżbieta Mirek
Elżbieta Mirek
MFMagdalena Filip
Magdalena Filip
WCWiesław Chwała
Wiesław Chwała
JSJadwiga Szymura
Jadwiga Szymura
SPSzymon Pasiut
Szymon Pasiut
ASAndrzej Szczudlik
Andrzej Szczudlik
There is no existing standard, evidence-based, scientific model for motor ability improvement in Huntington's Disease (HD) patients aimed at maintaining independent gait for as long as possible, or performing activities of daily living, the effectiveness of which would be supported by the results of studies using objective research tools. Under these circumstances, the aim of this study was to analyze the influence of motor ability rehabilitation on the spatial-temporal parameters of gait in HD patients. It was an experimental trial. The studied group consisted of 30 patients (17 women and 13 men) with HD. In hospital conditions, the patients participated in the 3-week motor ability l rehabilitation programme tailored to individual needs. The study group was tested using the Vicon 250 three-dimensional gait analysis system before and after the physical exercise programme. Walking speed after therapy increased for the left lower limb from 1.06 (SD 0.24) [m/s] to 1.21 (SD 0.23) [m/s], and for the right lower limb from 1.07 (SD 0.25) [m/s] to 1.20 (SD 0.25) [m/s]. The cycle length increased after the applied therapy for the left lower limb from 1.17 (SD 0.20) [m] to 1.23 (SD 0.19) [m]. The three-week motor ability rehabilitation programme positively influences spatial-temporal gait parameters in HD patients.

21 November 2025 in Aktualności Neurologiczne
Verified
Journal Article
Open access
PDF file
ASAnastazja Maria Sarna
Anastazja Maria Sarna
SPSzymon Pasiut
Szymon Pasiut
RNRyszard Nowak
Ryszard Nowak
SRStanisław Rusek
Stanisław Rusek
EMElżbieta Mirek
Elżbieta Mirek
KWKrzysztof Witold Wrześniewski
Krzysztof Witold Wrześniewski
Introduction and objective: The study aims to assess the validity of the Timed Up and Go test in patients with type IV spinal muscular atrophy and to examine its correlation with the 6-Minute Walk Test and the Hammersmith Functional Motor Scale – Expanded (HFMSE) over an eight-month period. Materials and methods: Fourteen adult, ambulant patients with spinal muscular atrophy type IV were included in the study. All patients were treated with intrathecal injections of nusinersen and were on a maintenance dosing schedule – once every four months. Assessments were performed twice, eight months apart. Results: HFMSE correlates negatively with the time required for the patient to complete the Timed Up and Go test. It also correlates positively with distance the patient is able to walk during the 6-Minute Walk Test. This demonstrates that all of these tools perform consistently in the assessment of spinal muscular atrophy patients. The Timed Up and Go test showed a moderate fall risk in four patients, and a high fall risk in one patient, which is significant for creating an individualised physiotherapy plan for each patient. Additionally, three patients were unable to perform the Timed Up and Go test again after eight months of treatment due to sustained injuries. In these cases, the test results indicated functional deterioration that was not captured by the other two assessments. Conclusions: The tests used in this study show consistent and complementary results. The Timed Up and Go test appears to be particularly sensitive for detecting functional decline in this patient group. This shows that the assessment tools used in the study have clinical utility and may be successfully used for planning rehabilitation and physiotherapeutic interventions tailored to each patient’s individual needs.

1 September 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
MSMateusz Siedlinski
Mateusz Siedlinski
PSP. Szczepaniak
P. Szczepaniak
RNR. Nosalski
R. Nosalski
ALAgnieszka H. Ludwig-Słomczyńska
Agnieszka H. Ludwig-Słomczyńska
TMTomasz Mikolajczyk
Tomasz Mikolajczyk
TGTomasz J. Guzik
Tomasz J. Guzik
Vascular dysfunction is an important element of hypertension pathogenesis and involves changes in numerous pathways important for disease development and target organ damage. We hypothesized that angiotensin II (AngII) affects transcriptome in the vasculature in a region-specific manner, which may help to identify genes causally related to the development of AngII-induced hypertension. Transcriptome of thoracic aorta, abdominal aorta and mesenteric arteries was profiled in 12 C57BL/6J wild-type (WT) hypertensive mice infused with AngII at a 490 ng/kg/min. dose for 2 weeks and 12 control, buffer infused mice using Illumina WG-6 v2.0 chip. Tissue organ bath experiments were performed using 750TOBS instrument. Sphingosine kinase 1 (Sphk1)−/− and appropriate WT mice were studied. Among over 16,000 RNA transcripts detected 21.5% were significantly (FDR corrected p < 0.05) differentially expressed in thoracic aorta between hypertensive and control mice, while such proportion was lower for abdominal aorta (0.3%) or mesenteric arteries (1.4%). Gene set enrichment and subsequent leading edge analyses performed on thoracic aorta transcriptome identified 4 genes present in the highest number of significantly AngII-affected biological pathways. Among them Sphk1 showed the highest significant expression fold change and independent quantitative PCR confirmed induction of Sphk1 (Induction Fold (IF) = 3.8, p < 0.001) and showed no change in expression of its isoenzyme Sphk2 (IF = 1.1, p = 0.42) in hypertensive as compared to control mice. Ex vivo inhibition of sphingosine-1-phosphate (S1P) synthesis significantly reduced vasoconstriction in response to KCl, phenylephrine or prostaglandin F2α (PGF2α) in intact and endothelium-denuded aortic rings. Sphk1−/− mice developed less severe AngII-induced hypertension (systolic BP 168 ± 3 vs. 180 ± 3 mmHg, p < 0.05) and lower heart hypertrophy as compared to WT hypertensive mice. Normotensive and hypertensive Sphk1−/−mice had significantly lower aortic contraction in response to PGF2α and KCl respectively as compared to appropriate WT animals. Significantly lower amounts of CD25+ and CD69+ T lymphocytes in the spleen and periaortic adipose tissue of hypertensive Sphk1−/− mice as compared to hypertensive WT mice were observed. This study shows that S1P is one of the key mediators of AngII-induced hypertension in vivo.

29 December 2017 in Rehabilitacja Medyczna
Verified
Journal Article
Open access
EMElżbieta Mirek
Elżbieta Mirek
KOKinga Opoka
Kinga Opoka
KKKrzysztof Kozioł
Krzysztof Kozioł
MFMagdalena Filip
Magdalena Filip
SPSzymon Pasiut
Szymon Pasiut
TTTomasz Tomaszewski
Tomasz Tomaszewski
Introduction: Stroke is not only a medical problem, but also - due to the permanent disability of the injured person - a significant social problem. A significant number of patients after a neurological event develop increased muscle tone. Upper motoneuron damage syndrome promotes pain, stiffness, muscle contracture and weakness, which can potentially delay or prevent success in the rehabilitation process. In the upper limb, the spastic pattern is most often expressed through adduction and internal rotation of the glenohumeral joint, combined with flexion in the elbow, radiocarpal joint and interphalangeal joints. The specificity of spasticity-type increased tension makes rehabilitation of patients suffering from this disorder one of the most difficult tasks of neurological rehabilitation. Aim: The aim of the study was to assess muscle tone and range of motion of the inferior limb in patients after ischemic stroke subjected to 4 cycles of intramuscular injections of a botulinum toxin preparation and subjected to motor rehabilitation. Research Project: Pilot experimental study. Methodology: The study was carried out in the Neurological Unit with Stroke Sub-unit and Sub-Department of Neurological Rehabilitation at John Paul II Specialist Hospital in Krakow in the period from September 2014 to November 2015. The study group consisted of 20 patients after ischemic stroke (13 men, 7 women), age 30 to 72. All patients completed a 4-cycle study, which included injections of the botulinum toxin preparation, combined with a 15-day cycle of individual rehabilitation exercises. Each training session lasted 90 minutes. In order to verify the therapeutic process, active and passive mobility was measured according to the SFTR method and the assessment of muscle tone level was done using the Modified Ashworth Scale. Results: The taken therapeutic actions caused a positive increase in mobility, mostly passive, in the glenohumeral-scapular, elbow and forearm as well as the radiocarpal joints. There was also a slight increase in active mobility of the upper limb joints. In the course of obtaining results, it was shown that the use of botulinum toxin, combined with the rehabilitation exercise programme, significantly reduced pathological muscle tone both within the elbow, radiocarpal joint, and the interphalangeal joints of the hands. Conclusions: The presented results showed that the use of the botulinum toxin combined with medical rehabilitation allows local treatment of spasticity without exposing patients to adverse systemic reactions associated with oral medication. In addition, it has a positive effect on the increase in passive and - to a lesser extent - active range of motion in the joints of the inferior limb.